<?xml version="1.0"?>
<law><site_title>Virginia Decoded</site_title><site_url>https://vacode.org</site_url><law_id>56263</law_id><section_number>32.1-73.22</section_number><catch_line>Information from hospitals, clinics, certain laboratories, and physicians supplied to Commissioner; statewide sickle cell disease registry</catch_line><edition url="https://vacode.org/2025/" slug="2025" current="TRUE" last_updated="">2025</edition><referred_to_by><reference>32.1-73.23</reference><reference>32.1-73.24</reference><reference>32.1-73.26</reference></referred_to_by><structure><unit label="title" level="1" order_by="1" identifier="32.1">Health</unit><unit label="chapter" level="2" order_by="1" identifier="2">Disease Prevention and Control</unit><unit label="article" level="3" order_by="1" identifier="22">Statewide Sickle Cell Disease Registry</unit></structure><text>
						<section id="A"><p><span class="prefix-number">A.</span> Each hospital, clinic, and independent pathology laboratory shall make available to the <span class="dictionary">Commissioner</span> or his agents information on patients having sickle cell disease. A physician shall report information on patients having sickle cell disease unless he has determined that a hospital, clinic, or in-state pathology laboratory has reported the information. Such information shall include the name, address, sex, race, diagnosis, trait status, newborn screening data, and any other pertinent identifying information regarding each such patient. Each hospital, clinic, independent pathology laboratory, or physician shall provide other available clinical information as defined by the <span class="dictionary">Board</span>. <a id="paragraph-206057" class="section-permalink" href="https://vacode.org/32.1-73.22/#A"><i class="fa fa-link"/></a></p></section>
						<section id="B"><p><span class="prefix-number">B.</span> From such information the <span class="dictionary">Commissioner</span> shall establish and maintain a statewide sickle cell disease registry. The purpose of the statewide sickle cell disease registry shall include: <a id="paragraph-206058" class="section-permalink" href="https://vacode.org/32.1-73.22/#B"><i class="fa fa-link"/></a></p></section>
						<section id="B1" class="indent-1"><p><span class="prefix-number">1.</span> Determining means of improving the diagnosis and treatment of sickle cell disease patients. <a id="paragraph-206059" class="section-permalink" href="https://vacode.org/32.1-73.22/#B1"><i class="fa fa-link"/></a></p></section>
						<section id="B2" class="indent-1"><p><span class="prefix-number">2.</span> Determining the need for and means of providing better long-term, follow-up care to sickle cell disease patients. <a id="paragraph-206060" class="section-permalink" href="https://vacode.org/32.1-73.22/#B2"><i class="fa fa-link"/></a></p></section>
						<section id="B3" class="indent-1"><p><span class="prefix-number">3.</span> Conducting epidemiological analyses of the incidence, prevalence, survival, and risk factors associated with the occurrence of sickle cell disease in Virginia. <a id="paragraph-206061" class="section-permalink" href="https://vacode.org/32.1-73.22/#B3"><i class="fa fa-link"/></a></p></section>
						<section id="B4" class="indent-1"><p><span class="prefix-number">4.</span> Improving rehabilitative programs for sickle cell disease patients. <a id="paragraph-206062" class="section-permalink" href="https://vacode.org/32.1-73.22/#B4"><i class="fa fa-link"/></a></p></section>
						<section id="B5" class="indent-1"><p><span class="prefix-number">5.</span> Assisting in the training of hospital personnel. <a id="paragraph-206063" class="section-permalink" href="https://vacode.org/32.1-73.22/#B5"><i class="fa fa-link"/></a></p></section>
						<section id="B6" class="indent-1"><p><span class="prefix-number">6.</span> Determining other needs of sickle cell disease patients and health personnel. <a id="paragraph-206064" class="section-permalink" href="https://vacode.org/32.1-73.22/#B6"><i class="fa fa-link"/></a></p></section></text><history>2024, c. 437.</history><metadata></metadata></law>
